Mentions
Extended reach
Total likes
Video views
AI synopsis
The posts collectively demonstrate strong agreement and high interest in the article, with examples such as references to the detailed analysis of the TARGIT-A trial, discussions of its benefits over traditional methods, and new tools like calculators for personalized treatment planning. The tone and choice of words emphasize the perceived revolutionary potential and patient-centered nature of the approach, underscoring its potential to significantly impact breast cancer treatment practices.
Most posts express strong support and enthusiasm for the intraoperative radiotherapy approach, highlighting its benefits and effectiveness.
Discussions show high interest by citing detailed analyses, new tools like calculators, and patient perspectives, indicating deep engagement with the topic.
Posts include references to scientific analyses, patient experiences, and implications for personalized medicine, reflecting sustained and meaningful engagement.
The emphasis on reduced side effects, improved quality of life, and personalized treatment suggests that the community perceives this as a significant advance in breast cancer care.
Thank you @Dr_Ivanoncologo. A video explanation of the further analysis of the TARGIT-A trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer is here https://t.co/fGDguskHBr https://t.co/K8PC5Ygd0Z
TARGIT-IORT radiotherapy during lumpectomy for breast cancer: effective in all subgroups, produces excellent prognosis even when there is a local relapse, and reduces deaths from heart attacks and other cancers. https://t.co/vKplK5hxZ2 https://t.co/fGDguskHBr
Dr. @jsvaidya talking about the latest TARGIT IORT analysis (here https://t.co/a8t1WBuMOb) They have a new calculator/nomogramic thing now https://t.co/lUvIuWrHkD Is this "personalized medicine" breast RT??? https://t.co/4pj4M3FxBA
Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: an innovative patient-centred treatment | British Journal of Cancer https://t.co/pjimxUWRLV
RT @jsvaidya: TARGIT-IORT radiotherapy during lumpectomy for breast cancer: effective in all subgroups, produces excellent prognosis even w…
Open Access UCL Research: Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: an innovative patient-centred treatment https://t.co/HSoxXUjxE7
TARGIT-IORT during surgery improves breast cancer treatment outcomes, offering a targeted, single-dose radiotherapy option that is as effective as traditional therapy but with fewer associated risks and benefits for…
Learn about the TARGIT trial, which assesses intraoperative radiotherapy delivered during lumpectomy as a patient-centered alternative to traditional radiotherapy, showing comparable effectiveness and fewer unrelated…
The TARGIT trial evaluated intraoperative radiotherapy, delivered during surgery, as an effective alternative to traditional radiotherapy. It showed comparable cancer recurrence prevention with fewer unrelated deaths…
The video discusses intraoperative radiotherapy (IORT) for breast cancer, highlighting the TARGIT trial results showing it as an effective, patient-centered alternative to traditional radiotherapy, with comparable…
Long-term outcomes of the TARGIT A trial show intraoperative radiotherapy given during lumpectomy is as effective as traditional radiotherapy, with fewer non-cancer related deaths. Discuss this patient-centered…
This video discusses the long-term outcomes of intraoperative radiotherapy during lumpectomy for breast cancer, comparing it with traditional radiotherapy. The TARGIT trial shows similar efficacy with fewer unrelated…
TARGIT IORT with Intrabeam for breast cancer at the Brazilian Breast Cancer Symposium 15 May 2021. The TARGIT trial studied intraoperative radiotherapy delivering radiation during surgery, showing comparable…
Thank you @Dr_Ivanoncologo. A video explanation of the further analysis of the TARGIT-A trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer is here https://t.co/fGDguskHBr https://t.co/K8PC5Ygd0Z
TARGIT-IORT during lumpectomy for #breastcancer is better for patients than whole-breast radiotherapy: As effective Greatly reduced non-breast-cancer deaths (10%→5%) Less pain & toxicity Improved quality of life & cosmetic outcome Lower cost to the NHS https://t.co/fGDguskHBr
@EuropHospital @ucl Here is a patient’s perspective. Also a short video explaining the latest paper https://t.co/fGDguskHBr Full paper https://t.co/vKplK5hxZ2 Blog about BJC paper https://t.co/456MkzqTz2 https://t.co/gGAEPwhfDH
RT @toddscarbrough: Dr. @jsvaidya talking about the latest TARGIT IORT analysis (here https://t.co/a8t1WBuMOb) They have a new calculator/…
RT @jsvaidya: TARGIT-IORT radiotherapy during lumpectomy for breast cancer: effective in all subgroups, produces excellent prognosis even w…
RT @toddscarbrough: Dr. @jsvaidya talking about the latest TARGIT IORT analysis (here https://t.co/a8t1WBuMOb) They have a new calculator/…
Dr. @jsvaidya talking about the latest TARGIT IORT analysis (here https://t.co/a8t1WBuMOb) They have a new calculator/nomogramic thing now https://t.co/lUvIuWrHkD Is this "personalized medicine" breast RT??? https://t.co/4pj4M3FxBA
RT @jsvaidya: TARGIT-IORT radiotherapy during lumpectomy for breast cancer: effective in all subgroups, produces excellent prognosis even w…
TARGIT-IORT radiotherapy during lumpectomy for breast cancer: effective in all subgroups, produces excellent prognosis even when there is a local relapse, and reduces deaths from heart attacks and other cancers. https://t.co/vKplK5hxZ2 https://t.co/fGDguskHBr
@CShahMD @mdAlvaradoMD @SorenBentzen @toddscarbrough @theRADSofKHAN Now combine both! Why? discussed here: https://t.co/WBJAVNQYGB Adressed in point 2
Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: an innovative patient-centred treatment | British Journal of Cancer https://t.co/pjimxUWRLV
(Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: an innovative patient-centred treatment) https://t.co/18uMsudbel
Open Access UCL Research: Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: an innovative patient-centred treatment https://t.co/HSoxXUjxE7